Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Treasury Shares (2022 - 2025)

Praxis Precision Medicines has reported Treasury Shares over the past 4 years, most recently at $501853.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $501853.0 for Q4 2025, up 123.57% from a year ago — trailing twelve months through Dec 2025 was $501853.0 (up 123.57% YoY), and the annual figure for FY2025 was $501853.0, up 123.57%.
  • Treasury Shares for Q4 2025 was $501853.0 at Praxis Precision Medicines, down from $516119.0 in the prior quarter.
  • Over the last five years, Treasury Shares for PRAX hit a ceiling of $856287.0 in Q2 2022 and a floor of $47145.0 in Q4 2023.
  • Median Treasury Shares over the past 4 years was $515857.5 (2025), compared with a mean of $458154.0.
  • Biggest five-year swings in Treasury Shares: tumbled 87.07% in 2024 and later skyrocketed 435.09% in 2025.
  • Praxis Precision Medicines' Treasury Shares stood at $49565.0 in 2022, then decreased by 4.88% to $47145.0 in 2023, then skyrocketed by 376.13% to $224473.0 in 2024, then soared by 123.57% to $501853.0 in 2025.
  • The last three reported values for Treasury Shares were $501853.0 (Q4 2025), $516119.0 (Q3 2025), and $515596.0 (Q2 2025) per Business Quant data.